Fig. 3From: Treatment persistence to tolvaptan in patients with autosomal dominant polycystic kidney disease: a secondary use of data analysis of patients in the IMADJIN® datasetTime to first liver function test (LFT) elevation. Ticks represent censoringBack to article page